It's little more than a "glorified Excel spreadsheet."
At least that's how New York University Stern School of Business economist Nouriel Roubini described blockchain technology earlier this month during a panel discussion at the Milken Institute Global Con
Over the past several years, a stark dividing line has essentially cleaved the Internet sector into two halves - the Wall Street favorites like Netflix (NFLX) whose valuation keeps surging and sends shares doubling almost every year, and has-been companies like Yelp (YELP) which still see some m
The Dow Jones todayprojected a 80-point gain Monday morning as markets reacted to Warren Buffett’s comments during Berkshire Hathaway Inc.’s (NYSE: BRK.A) annual shareholder meeting over the weekend in Omaha, Neb. According to Buffett, Berkshire is currently holding $100 billion in cash thanks to returns on roughly $14 billion of investments made in the first quarter of 2018. Buffett....More>>>
After struggling through deregulation, high oil prices, and a lengthy recession, airline stocks have rebounded in synchronization with the US stock market, with better global economies, and generally as a leading US economic indicator. A simple comparison of the six largest US airlines gives an encouraging picture of the recovery.
Of course, investors should be aware that airlines legendarily....More>>>
As you know by now, the Fed raised its target rate yesterday.
Ill have more to say about that in the days ahead. But today I want to address some news that could have even larger ramifications for markets and the economy. The mainstream media havent given it nearly the consideration it deserves.
What am I talking about?
President Trump announced plans today designed to punish....More>>>
CytomX Therapeutics, Inc. (the Company) is a clinical-stage, oncology-focused biopharmaceutical company with a vision of transforming lives with safer, more effective therapeutics. The Company is pioneering a novel class of investigat
Riverhead Capital Management LLC lifted its position in CoreCivic (NYSE:CXW) by 58.8% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 126,204 shares of the real estate investment trust’s stock after buying an additional 46,
Do what you like and are good at. - Charlie Munger
Syndax Pharmaceuticals (NASDAQ:SNDX) is an intriguing bioscience alerted to us by members of Integrated BioSci Investing. The company is innovating a stellar therapeutic pipeline that can deliver hopes to countless patients worl
TG Therapeutics (NASDAQ:TGTX) is an interesting bioscience that is approaching its growth inflection that is binary (i.e., a make or break catalytic event). There is a good chance that years of efforts in brewing a promising pipeline of potential blockbusters are about to p